BP-1200

N/A

Report date: 2022/05/10 11:42:40

Base Information

Drug NameBP-1200
Drug Alias NameBP1200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of Action5'-nucleotidase inhibitorsT lymphocytes stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects
Targets5'-nucleotidase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrightpath Biotherapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrightpath Biotherapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A